Mountcastle David's Form 4 filing
Privia Health Group, Inc. (PRVA) · filed Mar 12, 2025
- Accession no.
- 0001759655-25-000031
- Filed
- Mar 12, 2025
- Trade date
- Mar 10-11, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $141.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mountcastle DavidCIK 0001858396 | Officer (EVP & Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Stock, par value $0.01 per share | SSaleDisposed | −2,979 | $24.53 | −$73,074.87 | 188,178 | Direct | |
| Mar 11, 2025 | Common Stock, par value $0.01 per share | SSaleDisposed | −2,872 | $23.88 | −$68,583.36 | 185,306 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.